RxDoctor Payments Data

Stephanie Breault

Family · Forsyth, MONPI 1619556016

Payments from drug & device makers

$2,380in general payments, 2019–2025

Across 152 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$628
  • AstraZeneca$318
  • AbbVie$268
  • Novo Nordisk$201
  • Otsuka America Pharmaceutical, Inc.$145
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$107
  • plus $713 from 21 others

What the payments were for

  • Food & beverage$2,369100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,380 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide33$45,522
OzempicSemaglutide36$35,211
FarxigaDapagliflozin Propanediol23$23,429
TrulicityDulaglutide14$20,923
JardianceEmpagliflozin17$19,793
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$17,388
EliquisApixaban12$10,597
Spiriva RespimatTiotropium Bromide19$9,916
MyrbetriqMirabegron16$7,247
PremarinEstrogens, Conjugated11$5,542
SymbicortBudesonide/Formoterol Fumarate15$4,712
VascepaIcosapent Ethyl11$3,856
Albuterol Sulfate HfaAlbuterol Sulfate113$1,721
Fluticasone Propionate105$1,452
Lidocaine12$1,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$628$66,44647 claims
Novo NordiskOzempic$201$35,21136 claims
Boehringer IngelheimJardiance, Spiriva Respimat$53$29,70836 claims
AstraZenecaFarxiga, Symbicort$318$28,14038 claims
GSKTrelegy Ellipta$37$17,38826 claims
PfizerEliquis, Premarin$75$16,13923 claims
Astellas Pharma US IncMyrbetriq$40$7,24716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Forsyth

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →